Evidence map›Paper›PMID 41777642›Full record

ArticleJBMR plus2026

Impact of oral phosphate supplements and active vitamin D treatment on dentoalveolar features of X-linked hypophosphatemia.

Julien Po, Elis J Lira Dos Santos, Amandine François, Axelle Cauliez, Volha V Zhukouskaya, Agnes Linglart, Catherine Chaussain, Claire Bardet

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JBMR plus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Julien PoInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.ORCID https://orcid.org/0009-0001-6811-8318
Elis J Lira Dos SantosInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.
Amandine FrançoisInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.
Axelle CauliezInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.
Volha V ZhukouskayaInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.
Agnes LinglartInserm U1185, AP-HP, DMU SEA, Endocrinology and Diabetes for Children, Reference Center for Rare Diseases of the Calcium and Phosphate Metabolism, OSCAR filière, EndoRare, and BOND ERN, Bicêtre Hospital, Paris-Saclay University, F-94270 Le Kremlin-Bicêtre, France.ORCID https://orcid.org/0000-0003-3455-002X
Catherine ChaussainInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.ORCID https://orcid.org/0000-0002-3463-3936
Claire BardetInserm, Santé Orale, Université Paris Cité and Sorbonne Paris Nord, F-92120 Montrouge, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

X-linked hypophosphatemia (XLH), the most common form of genetic rickets (1/20000 births), results in the disruption of skeletal and dental mineralization. Oral features include dentinomalacia, spontaneous dental abscesses, and a high susceptibility to periodontitis. The association of phosphate supplementation and active vitamin D analogs (PO

Indexed as

dentinomalaciaHyp miceosteomalaciaPHEXricketsX-linked hypophosphatemia (XLH)

Identifiers

PMID41777642
PMCPMC12951072

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.